Literature DB >> 33575357

Marked Changes in Serum Amyloid A Distribution and High-Density Lipoprotein Structure during Acute Inflammation.

Shitsuko Shimano1, Ryunosuke Ohkawa2, Mayu Nambu2, Mai Sasaoka2, Azusa Yamazaki1, Yuki Fujii1, Yuna Horiuchi2, Shao-Jui Lai2, Takahiro Kameda2, Naoya Ichimura1, Koji Fujita3, Shuji Tohda1, Minoru Tozuka2,4.   

Abstract

High-density lipoprotein- (HDL-) cholesterol measurements are generally used in the diagnosis of cardiovascular diseases. However, HDL is a complicated heterogeneous lipoprotein, and furthermore, it can be converted into dysfunctional forms during pathological conditions including inflammation. Therefore, qualitative analysis of pathophysiologically diversified HDL forms is important. A recent study demonstrated that serum amyloid A (SAA) can remodel HDL and induce atherosclerosis not only over long periods of time, such as during chronic inflammation, but also over shorter periods. However, few studies have investigated rapid HDL remodeling. In this study, we analyzed HDL samples from patients undergoing orthopedic surgery inducing acute inflammation. We enrolled 13 otherwise healthy patients who underwent orthopedic surgery. Plasma samples were obtained on preoperative day and postoperative days (POD) 1-7. SAA, apolipoprotein A-I (apoA-I), and apolipoprotein A-II (apoA-II) levels in the isolated HDL were determined. HDL particle size, surface charge, and SAA and apoA-I distributions were also analyzed. In every patient, plasma SAA levels peaked on POD3. Consistently, the HDL apoA-I : apoA-II ratio markedly decreased at this timepoint. Native-polyacrylamide gel electrophoresis and high-performance liquid chromatography revealed the loss of small HDL particles during acute inflammation. Furthermore, HDL had a decreased negative surface charge on POD3 compared to the other timepoints. All changes observed were SAA-dependent. SAA-dependent rapid changes in HDL size and surface charge were observed after orthopedic surgery. These changes might affect the atheroprotective functions of HDL, and its analysis can be available for the qualitative HDL assessment.
Copyright © 2021 Shitsuko Shimano et al.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33575357      PMCID: PMC7861920          DOI: 10.1155/2021/9241259

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


  36 in total

1.  HDL content and composition in acute phase response in three species: triglyceride enrichment of HDL a factor in its decrease.

Authors:  V G Cabana; J R Lukens; K S Rice; T J Hawkins; G S Getz
Journal:  J Lipid Res       Date:  1996-12       Impact factor: 5.922

Review 2.  Targeting high-density lipoproteins: increasing de novo production versus decreasing clearance.

Authors:  Arshag D Mooradian; Michael J Haas
Journal:  Drugs       Date:  2015-05       Impact factor: 9.546

3.  HIV and cardiovascular diseases risk: exploring the interplay between T-cell activation, coagulation, monocyte subsets, and lipid subclass alterations.

Authors:  Eman Teer; Danzil E Joseph; Natasha Driescher; Theo A Nell; Leanne Dominick; Natasha Midgley; Gaurang Deshpande; Martin J Page; Etheresia Pretorius; Nicholas J Woudberg; Sandrine Lecour; Richard H Glashoff; M Faadiel Essop
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-15       Impact factor: 4.733

4.  Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity.

Authors:  Tomáš Vaisar; Chongren Tang; Ilona Babenko; Patrick Hutchins; Jake Wimberger; Anthony F Suffredini; Jay W Heinecke
Journal:  J Lipid Res       Date:  2015-05-20       Impact factor: 5.922

5.  A brief elevation of serum amyloid A is sufficient to increase atherosclerosis.

Authors:  Joel C Thompson; Colton Jayne; Jennifer Thompson; Patricia G Wilson; Meghan H Yoder; Nancy Webb; Lisa R Tannock
Journal:  J Lipid Res       Date:  2014-11-26       Impact factor: 5.922

6.  Changes in human serum amyloid A and C-reactive protein after etiocholanolone-induced inflammation.

Authors:  K P McAdam; R J Elin; J D Sipe; S M Wolff
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

7.  Effects of serum amyloid A protein (SAA) on composition, size, and density of high density lipoproteins in subjects with myocardial infarction.

Authors:  P M Clifton; A M Mackinnon; P J Barter
Journal:  J Lipid Res       Date:  1985-12       Impact factor: 5.922

8.  Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial.

Authors:  Michiel L Bots; Frank L Visseren; Gregory W Evans; Ward A Riley; James H Revkin; Charles H Tegeler; Charles L Shear; William T Duggan; Ralph M Vicari; Diederick E Grobbee; John J Kastelein
Journal:  Lancet       Date:  2007-07-14       Impact factor: 79.321

9.  HDL remodeling during the acute phase response.

Authors:  Anisa Jahangiri; Maria C de Beer; Victoria Noffsinger; Lisa R Tannock; Chandrashekar Ramaiah; Nancy R Webb; Deneys R van der Westhuyzen; Frederick C de Beer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-11-13       Impact factor: 8.311

10.  Quantitative Prediction of Human Pharmacokinetics and Pharmacodynamics of CKD519, a Potent Inhibitor of Cholesteryl Ester Transfer Protein (CETP).

Authors:  Suein Choi; Seunghoon Han; Sangil Jeon; Dong-Seok Yim
Journal:  Pharmaceutics       Date:  2019-07-15       Impact factor: 6.321

View more
  1 in total

1.  Regulation of Atherosclerosis by Toll-Like Receptor 4 Induced by Serum Amyloid 1: A Systematic In Vitro Study.

Authors:  Jinhui Chen; Gang Liu; Yan Hong; Jing Han; Zhe Yang; Yanping Yang; Hong Li; Shumin Wang; Lili Jue; Qi Wang
Journal:  Biomed Res Int       Date:  2022-09-15       Impact factor: 3.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.